Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.
Jing Quan LimDachuan HuangTiffany TangDaryl TanYurike LaurensiaRou-Jun PengEsther Kam Yin WongDaryl Ming Zhe CheahBurton Kuan Hui ChiaJabed IqbalNicholas Francis GrigoropoulosMaarja-Liisa NairismägiCedric Chuan Young NgVikneswari RajasegaranHuangming HongSeok Jin KimJunhun ChoEric Wai-Choi TseBenjamin MowQi-Chun CaiLi-Mei PoonQing-Qing CaiJing TanJason Yongsheng ChanJohnathan Xiande LimYeow Tee GohColin PhippsOlaf RötzschkeChee Leong ChengJeslin Chian Hung HaLay Poh KhooYvonne Su Ming LohRex Kwok-Him Au-YeungThomas Sau-Yan ChanYok-Lam KwongWilliam Ying Khee HwangWon Seog KimJin-Xin BeiTongyu LinChoon-Kiat OngSoon Thye LimPublished in: Leukemia (2020)